BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 28100425)

  • 1. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
    McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
    Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of adjunctive antidepressant treatment for bipolar depression.
    Sachs GS; Nierenberg AA; Calabrese JR; Marangell LB; Wisniewski SR; Gyulai L; Friedman ES; Bowden CL; Fossey MD; Ostacher MJ; Ketter TA; Patel J; Hauser P; Rapport D; Martinez JM; Allen MH; Miklowitz DJ; Otto MW; Dennehy EB; Thase ME
    N Engl J Med; 2007 Apr; 356(17):1711-22. PubMed ID: 17392295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.
    Sidor MM; Macqueen GM
    J Clin Psychiatry; 2011 Feb; 72(2):156-67. PubMed ID: 21034686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression.
    Yatham LN; Arumugham SS; Kesavan M; Ramachandran K; Murthy NS; Saraf G; Ouyang Y; Bond DJ; Schaffer A; Ravindran A; Ravindran N; Frey BN; Daigneault A; Beaulieu S; Lam RW; Kondapuram N; Reddy MS; Bhandary RP; Ashok MV; Ha K; Ahn YM; Milev R; Wong H; Reddy YCJ;
    N Engl J Med; 2023 Aug; 389(5):430-440. PubMed ID: 37530824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials.
    Muralidharan K; Ali M; Silveira LE; Bond DJ; Fountoulakis KN; Lam RW; Yatham LN
    J Affect Disord; 2013 Sep; 150(2):408-14. PubMed ID: 23735211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
    Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
    Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.
    Gijsman HJ; Geddes JR; Rendell JM; Nolen WA; Goodwin GM
    Am J Psychiatry; 2004 Sep; 161(9):1537-47. PubMed ID: 15337640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of clinical response to active drugs and placebo on antipsychotics and mood stabilizers relative efficacy for bipolar depression and mania: A meta-regression analysis.
    Bartoli F; Clerici M; Di Brita C; Riboldi I; Crocamo C; Carrà G
    J Psychopharmacol; 2018 Apr; 32(4):416-422. PubMed ID: 29338576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.
    Post RM; Altshuler LL; Frye MA; Suppes T; Rush AJ; Keck PE; McElroy SL; Denicoff KD; Leverich GS; Kupka R; Nolen WA
    Bipolar Disord; 2001 Oct; 3(5):259-65. PubMed ID: 11912569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive antidepressants for the acute treatment of bipolar depression: A systematic review and meta-analysis.
    Hu Y; Zhang H; Wang H; Wang C; Kung S; Li C
    Psychiatry Res; 2022 May; 311():114468. PubMed ID: 35248807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.
    Perlis RH; Welge JA; Vornik LA; Hirschfeld RM; Keck PE
    J Clin Psychiatry; 2006 Apr; 67(4):509-16. PubMed ID: 16669715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants for bipolar disorder: A meta-analysis of randomized, double-blind, controlled trials.
    Zhang Y; Yang H; Yang S; Liang W; Dai P; Wang C; Zhang Y
    Neural Regen Res; 2013 Nov; 8(31):2962-74. PubMed ID: 25206617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.
    Papakostas GI; Shelton RC; Smith J; Fava M
    J Clin Psychiatry; 2007 Jun; 68(6):826-31. PubMed ID: 17592905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review.
    Van Lieshout RJ; MacQueen GM
    Br J Psychiatry; 2010 Apr; 196(4):266-73. PubMed ID: 20357301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.